A clinical trial titled "Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)" was registered as of August 21, 2026. The trial, identified as NCT07639684, is listed with a phase of not applicable. Its current status is not yet recruiting. This entry relates to glucagon, which carries approved regulatory status. No enrollment, results, or outcome data have been posted for this study at this time. The listing reflects only the trial's registration details as provided. Interested readers can consult the official record for further updates as the study progresses. For general background on this compound, readers can refer to the compound overview.
Glucagon-Related Trial NCT07639684 Registered, Not Yet Recruiting
See the full glucagon overview
Source: https://clinicaltrials.gov/study/NCT07639684